Citation: Chunhui Wu, Qiuyue Liu, Yikun Wang, Zhengxin Xie, Honglin Huang, Ningxi Li, Xiaodan Wei, Geng Yang, Tingting Li, Hong Yang, Shun Li, Xiang Qin, Yiyao Liu. Tirapazamine encapsulated hyaluronic acid nanomicelles realized targeted and efficient photo-bioreductive cascading cancer therapy[J]. Chinese Chemical Letters, ;2021, 32(8): 2400-2404. doi: 10.1016/j.cclet.2021.02.060 shu

Tirapazamine encapsulated hyaluronic acid nanomicelles realized targeted and efficient photo-bioreductive cascading cancer therapy

Chunhui Wu ^{a, *,} ,
Qiuyue Liu ^a ,
Yikun Wang ^a ,
Zhengxin Xie ^a ,
Honglin Huang ^a ,
Ningxi Li ^a ,
Xiaodan Wei ^a ,
Geng Yang ^a ,
Tingting Li ^a ,
Hong Yang ^a ,
Shun Li ^a ,
Xiang Qin ^a ,
Yiyao Liu ^{a, b, *,}

a.
Department of Biophysics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610054, China
b.
TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China

wuchunhui@uestc.edu.cn

liuyiyao@uestc.edu.cn

Received Date: 6 January 2021
Revised Date: 24 February 2021
Accepted Date: 25 February 2021
Available Online: 27 February 2021

Figures(4)

Currently, architecting a rational and efficient nanoplatform combing with multi-therapeutic modalities is highly obligatory for advanced cancer treatment. In order to remedy the self-limiting hypoxic dilemma of photodynamic therapy (PDT), herein, a facile photosensitizer (i.e., chlorin e6, Ce6) and bioreductive prodrug (i.e., tirapazamine, TPZ)-coloaded hyaluronic acid (HA) nanomicelles (denoted as TPZ@HA-Ce6) was developed for the cascading mode of photo-bioreductive cancer therapy. Taking the typical advantage of Ce6 coupled HA conjugate, TPZ was easily and successfully accommodated into the hydrophobic core of HA-Ce6 nanomicelles, yielding TPZ@HA-Ce6. It showed good dispersibility and stability with the hydrodynamic size of ca. 170 nm. It targeted the CD44 overexpressed cancer cells by receptor-mediated endocytosis way and killed them effectively with singlet oxygen and the subsequent TPZ radicals resulting from the oxygen depletion of PDT. The later was further verified by the hypoxia probe in vivo. Using murine mammary carcinoma 4 T1 model, TPZ@HA-Ce6 nanomicelles exhibited cascading and synergistic anticancer effect of PDT and TPZ bioreductive therapy compared with each monotherapy. This work suggests the promising prospect of the hybrid hyaluronic nanomicelles for highly efficient cancer combination treatment.
- Hyaluronic acid,
- Photosensitizer,
- Bioreductive prodrug,
- Hypoxia,
- Cascading cancer therapy
1. [1]
  S. Rawal, M.M. Patel, J. Control. Release 301 (2019) 76-109 doi: 10.1016/j.jconrel.2019.03.015
2. [2]
  L.M. Yang, P. Gao, Y.L. Huang, et al., Chin. Chem. Lett. 30 (2019) 1293–1296 doi: 10.1016/j.cclet.2019.03.032
3. [3]
  L. Li, Y.S. Chen, W.J. Chen, et al., Chin. Chem. Lett. 30 (2019) 1689–1703 doi: 10.1016/j.cclet.2019.04.017
4. [4]
  J.P. Celli, B.Q. Spring, I. Rizvi, et al., Chem. Rev. 110 (2010) 2795-2838 doi: 10.1021/cr900300p
5. [5]
  X. Li, N. Kwon, T. Guo, et al., Angew Chem. Int. Ed. 57 (2018) 11522-11531 doi: 10.1002/anie.201805138
6. [6]
  M.I. Koukourakis, A. Giatromanolaki, J. Skarlatos, et al., Cancer Res. 61 (2001) 1830-1832
7. [7]
  Z. Huang, Q. Chen, A. Shakil, et al., Photochem. Photobiol. 78 (2003) 496-502 doi: 10.1562/0031-8655(2003)078<0496:HETTCK>2.0.CO;2
8. [8]
  G. Yang, L. Xu, Y. Chao, et al., Nat. Commun. 8 (2017) 902 doi: 10.1038/s41467-017-01050-0
9. [9]
  Z. Zhang, R. Wang, X. Huang, et al., ACS Appl. Mater. Interfaces 12 (2020) 5680-5694 doi: 10.1021/acsami.9b23325
10. [10]
  W.R. Wilson, M.P. Hay, Nat. Rev. Cancer 11 (2011) 393-410 doi: 10.1038/nrc3064
11. [11]
  L. Feng, L. Cheng, Z. Dong, et al., ACS Nano 11 (2017) 927-937 doi: 10.1021/acsnano.6b07525
12. [12]
  Y. Liu, Y. Liu, W. Bu, et al., Angew Chem. Int. Ed. 54 (2015) 8105-8109 doi: 10.1002/anie.201500478
13. [13]
  Y. Shao, B. Liu, Z. Di, et al., J. Am. Chem. Soc. 142 (2020) 3939-3946 doi: 10.1021/jacs.9b12788
14. [14]
  C. Qian, P. Feng, J. Yu, et al., Angew Chem. Int. Ed. 56 (2017) 2588-2593 doi: 10.1002/anie.201611783
15. [15]
  D. Guo, S. Xu, N. Wang, et al., Biomaterials 144 (2017) 188-198 doi: 10.1016/j.biomaterials.2017.08.032
16. [16]
  Y. Wang, Y. Xie, J. Li, et al., ACS Nano 11 (2017) 2227-2238 doi: 10.1021/acsnano.6b08731
17. [17]
  D. Chen, Y. Tang, J. Zhu, et al., Biomaterials 221 (2019) 119422 doi: 10.1016/j.biomaterials.2019.119422
18. [18]
  K.M. Ihsanullah, B.N. Kumar, Y. Zhao, et al., Biomaterials 245 (2020) 119982 doi: 10.1016/j.biomaterials.2020.119982
19. [19]
  H. Kim, H. Jeong, S. Han, et al., Biomaterials 123 (2017) 155-171
20. [20]
  P. Kesharwani, S. Banerjee, S. Padhye, et al., Biomacromolecules 16 (2015) 3042-3053 doi: 10.1021/acs.biomac.5b00941
21. [21]
  Q. Zhao, J. Liu, W. Zhu, et al., Acta Biomater. 23 (2015) 147-156 doi: 10.1016/j.actbio.2015.05.010
22. [22]
  J. Han, W. Park, S.J. Park, et al., ACS Appl. Mater. Interfaces 8 (2016) 7739-7747 doi: 10.1021/acsami.6b01664
23. [23]
  W. Miao, G. Shim, C.M. Kang, et al., Biomaterials 34 (2013) 9638-9647 doi: 10.1016/j.biomaterials.2013.08.058
24. [24]
  Y. Sakurai, H. Harashima, Expert Opin. Drug Del. 16 (2019) 915-936 doi: 10.1080/17425247.2019.1645115
25. [25]
  H.Y. Yoon, H. Koo, K.Y. Choi, et al., Biomaterials 33 (2012) 3980-3989 doi: 10.1016/j.biomaterials.2012.02.016
26. [26]
  H.J. Cho, H.Y. Yoon, H. Koo, et al., Biomaterials 32 (2011) 7181-7190 doi: 10.1016/j.biomaterials.2011.06.028
27. [27]
  W. Li, C. Zheng, Z. Pan, et al., Biomaterials 101 (2016) 10-19 doi: 10.1016/j.biomaterials.2016.05.019
28. [28]
  Y. Li, L. Sutrisno, Y. Hou, et al., Chem. Commun (Camb). 56 (2020) 9978-9981 doi: 10.1039/d0cc03667f
29. [29]
  X. Liang, L. Fang, X. Li, et al., Biomaterials 132 (2017) 72-84 doi: 10.1016/j.biomaterials.2017.04.006
30. [30]
  F.F. Xue, W.X. Du, S.X. Chen, et al., ACS Appl. Bio Mater. 3 (2020) 8962-8969 doi: 10.1021/acsabm.0c01223
31. [31]
  Y. Huang, K.M. Du, Z.H. Xue, et al., Leukemia 17 (2003) 2065−2073 doi: 10.1038/sj.leu.2403141
1. [1]
  Zhe Li , Ping-Zhao Liang , Li Xu , Fei-Yu Yang , Tian-Bing Ren , Lin Yuan , Xia Yin , Xiao-Bing Zhang . Three positive charge nonapoptotic-induced photosensitizer with excellent water solubility for tumor therapy. Chinese Chemical Letters, 2024, 35(8): 109190-. doi: 10.1016/j.cclet.2023.109190
2. [2]
  Du Liu , Yuyan Li , Hankun Zhang , Benhua Wang , Chaoyi Yao , Minhuan Lan , Zhanhong Yang , Xiangzhi Song . Three-in-one erlotinib-modified NIR photosensitizer for fluorescence imaging and synergistic chemo-photodynamic therapy. Chinese Chemical Letters, 2025, 36(2): 109910-. doi: 10.1016/j.cclet.2024.109910
3. [3]
  Di Zhang , Xu He , Xiaoying Kang , Xue Meng , Ji Qi , Zhifang Wu , Ningbo Li . A photo-accelerated nanoplatform for image-guided synergistic chemo-photodynamic therapy. Chinese Chemical Letters, 2025, 36(12): 110942-. doi: 10.1016/j.cclet.2025.110942
4. [4]
  Yueying Wang , Jianming Xiong , Linwei Xin , Yuanyuan Li , He Huang , Wenjun Miao . Photosensitizer-synergized g-carbon nitride nanosheets with enhanced photocatalytic activity for eradicating drug-resistant bacteria and promoting wound healing. Chinese Chemical Letters, 2025, 36(4): 110003-. doi: 10.1016/j.cclet.2024.110003
5. [5]
  Qihang Wu , Hui Wen , Wenhai Lin , Tingting Sun , Zhigang Xie . Alkyl chain engineering of boron dipyrromethenes for efficient photodynamic antibacterial treatment. Chinese Chemical Letters, 2024, 35(12): 109692-. doi: 10.1016/j.cclet.2024.109692
6. [6]
  Cheng He , Renlan Huang , Lingling Wei , Qiuhui He , Jinbo Liu , Jiao Chen , Ge Gao , Cheng Yang , Wanhua Wu . Uncovering the mask of sensitizers to switch on the TTA-UC emission by supramolecular host-guest complexation. Chinese Chemical Letters, 2025, 36(4): 110103-. doi: 10.1016/j.cclet.2024.110103
7. [7]
  Li Fu , Ziye Su , Shuyang Wu , Yanfen Cheng , Chuan Hu , Jinming Zhang . Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy. Chinese Chemical Letters, 2025, 36(5): 110227-. doi: 10.1016/j.cclet.2024.110227
8. [8]
  Ling-Ling Wu , Xiangchuan Meng , Qingyang Zhang , Xiaowan Han , Feiya Yang , Qinghua Wang , Hai-Yu Hu , Nianzeng Xing . Heavy-atom engineered hypoxia-responsive probes for precisive photoacoustic imaging and cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108663-. doi: 10.1016/j.cclet.2023.108663
9. [9]
  Chao Zhang , Ai-Feng Liu , Shihui Li , Fang-Yuan Chen , Jun-Tao Zhang , Fang-Xing Zeng , Hui-Chuan Feng , Ping Wang , Wen-Chao Geng , Chuan-Rui Ma , Dong-Sheng Guo . A supramolecular formulation of icariin@sulfonatoazocalixarene for hypoxia-targeted osteoarthritis therapy. Chinese Chemical Letters, 2025, 36(1): 109752-. doi: 10.1016/j.cclet.2024.109752
10. [10]
  Huijie An , Chen Yang , Zhihui Jiang , Junjie Yuan , Zhongming Qiu , Longhao Chen , Xin Chen , Mutu Huang , Linlang Huang , Hongju Lin , Biao Cheng , Hongjiang Liu , Zhiqiang Yu . Luminescence-activated Pt(Ⅳ) prodrug for in situ triggerable cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109134-. doi: 10.1016/j.cclet.2023.109134
11. [11]
  Fa Wang , Yu Chen , Hui Chao . Ruthenium(II) Complexes as Photoactivated Chemo-Prodrugs for Hypoxic Tumor Therapy. University Chemistry, 2025, 40(7): 200-212. doi: 10.12461/PKU.DXHX202410024
12. [12]
  Liangliang Jia , Ye Hong , Xinyu He , Ying Zhou , Liujiao Ren , Hongjun Du , Bin Zhao , Bin Qin , Zhe Yang , Di Gao . Fighting hypoxia to improve photodynamic therapy-driven immunotherapy: Alleviating, exploiting and disregarding. Chinese Chemical Letters, 2025, 36(2): 109957-. doi: 10.1016/j.cclet.2024.109957
13. [13]
  Yiling Li , Zekun Gao , Xiuxiu Yue , Minhuan Lan , Xiuli Zheng , Benhua Wang , Shuang Zhao , Xiangzhi Song . FRET-based two-photon benzo[a] phenothiazinium photosensitizer for fluorescence imaging-guided photodynamic therapy. Chinese Chemical Letters, 2024, 35(7): 109133-. doi: 10.1016/j.cclet.2023.109133
14. [14]
  Li Li , Jiale Wen , Xiaojun Zhang , Shuwen Fu , Zixuan Chen , Kai Huang , Luyue Fang , Tinghe Zhao , Peipei Zhang , Xingshu Li . A near-infrared naphthalocyanine photosensitizer with superior light absorption and renal clearance for type-Ⅰ photodynamic and photothermal combination therapy. Chinese Chemical Letters, 2025, 36(6): 110290-. doi: 10.1016/j.cclet.2024.110290
15. [15]
  Lin Li , Bingjun Sun , Jin Sun , Lin Chen , Zhonggui He . Binary prodrug nanoassemblies combining chemotherapy and ferroptosis activation for efficient triple-negative breast cancer therapy. Chinese Chemical Letters, 2024, 35(10): 109538-. doi: 10.1016/j.cclet.2024.109538
16. [16]
  Lintao Wu , Yujia Meng , Xumei Zheng , Yiqiao Bai , Chun Han , Zhijun Wang , Jie Yang , Xiaobi Jing , Yong Yao . Pillar[5]arene based prodrug as a GSH-responsive SO₂ nanogenerator for effective gas cancer therapy. Chinese Chemical Letters, 2025, 36(9): 110808-. doi: 10.1016/j.cclet.2024.110808
17. [17]
  Xin Lv , Hongxing Zhang , Kaibo Duan , Wenhui Dai , Zhihui Wen , Wei Guo , Junsheng Hao . Lighting the Way Against Cancer: Photodynamic Therapy. University Chemistry, 2024, 39(5): 70-79. doi: 10.3866/PKU.DXHX202309090
18. [18]
  Zekun Gao , Xiuli Zheng , Weimin Liu , Jie Sha , Shuaishuai Bian , Haohui Ren , Jiasheng Wu , Wenjun Zhang , Chun-Sing Lee , Pengfei Wang . GSH-activatable copper-elsinochrome off-on photosensitizer for combined specific NIR-Ⅱ two-photon photodynamic/chemodynamic therapy. Chinese Chemical Letters, 2025, 36(3): 109874-. doi: 10.1016/j.cclet.2024.109874
19. [19]
  Haoran Hou , Siwen Wei , Yutong Shao , Yingnan Wu , Gaobo Hong , Jing An , Jiarui Tian , Jianjun Du , Fengling Song , Xiaojun Peng . A 690-nm-excitable type Ⅰ & Ⅱ photosensitizer based on biotinylation of verteporfin for photodynamic therapy of deep-seated orthotopic breast tumors. Chinese Chemical Letters, 2025, 36(6): 110315-. doi: 10.1016/j.cclet.2024.110315
20. [20]
  Wenjia Wang , Xingyue He , Xiaojie Wang , Tiantian Zhao , Osamu Muraoka , Genzoh Tanabe , Weijia Xie , Tianjiao Zhou , Lei Xing , Qingri Jin , Hulin Jiang . Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (Ⅳ) prodrug delivery and enhanced colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108656-. doi: 10.1016/j.cclet.2023.108656

Get Citation

PDF

XML

Metrics

PDF Downloads(10)
Abstract views(1415)
HTML views(68)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142